Literature DB >> 12444147

Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents.

Alison C MacKinnon1, Avril Buckley, Edwin R Chilvers, Adriano G Rossi, Christopher Haslett, Tariq Sethi.   

Abstract

Neutrophils are a vital component of the early acute inflammatory response, but can cause profound tissue damage when activated to excess or prevented from undergoing apoptosis. However, much remains unknown about the intracellular signaling pathways regulating neutrophil activity. The structurally diverse neutrophil-priming agents platelet-activating factor, TNF-alpha, and the substance P analog [D-Arg(6), D-Trp(7,9),N(me)Phe(8)]-substance P(6-11) (SP-G) stimulated a rapid increase in sphingosine kinase activity in freshly isolated human neutrophils. This activity was blocked by preincubation with the sphingosine kinase inhibitor N,N-dimethylsphingosine (DMS). DMS also inhibited the increase in intracellular calcium concentration stimulated by platelet-activating factor, fMLP, and SP-G. This suggests that the increase in intracellular calcium concentration by these agents is dependent on sphingosine kinase activation and the generation of sphingosine-1-phosphate. Changes in cell polarization and the augmentation of the fMLP-induced superoxide anion generation, by all priming agents were also inhibited by DMS, while only the superoxide anion release was blocked by the phosphatidylinositol 3-kinase inhibitor LY294002. Moreover, SP-G and GM-CSF inhibited constitutive neutrophil apoptosis which was completely blocked by DMS. These results suggest a novel role for sphingosine kinase in the regulation of neutrophil priming.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444147     DOI: 10.4049/jimmunol.169.11.6394

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Sphingosine 1-phosphate, a diffusible calcium influx factor mediating store-operated calcium entry.

Authors:  Kiyoshi Itagaki; Carl J Hauser
Journal:  J Biol Chem       Date:  2003-05-13       Impact factor: 5.157

2.  Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion.

Authors:  Yanjun Shi; Hasibur Rehman; Venkat K Ramshesh; Justin Schwartz; Qinlong Liu; Yasodha Krishnasamy; Xun Zhang; John J Lemasters; Charles D Smith; Zhi Zhong
Journal:  J Hepatol       Date:  2011-07-12       Impact factor: 25.083

3.  Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis.

Authors:  M Karima; A Kantarci; T Ohira; H Hasturk; V L Jones; B-H Nam; A Malabanan; P C Trackman; J A Badwey; T E Van Dyke
Journal:  J Leukoc Biol       Date:  2005-08-04       Impact factor: 4.962

4.  Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase.

Authors:  Alexander A Chumanevich; Deepak Poudyal; Xiangli Cui; Tia Davis; Patricia A Wood; Charles D Smith; Lorne J Hofseth
Journal:  Carcinogenesis       Date:  2010-08-05       Impact factor: 4.944

5.  Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury.

Authors:  Li-Wen Lai; Kim-Chong Yong; Yeong-Hau H Lien
Journal:  Kidney Int       Date:  2011-12-21       Impact factor: 10.612

Review 6.  Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis.

Authors:  Mel Pilar Espaillat; Richard R Kew; Lina M Obeid
Journal:  Adv Biol Regul       Date:  2016-11-14

7.  Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase.

Authors:  Leo R Fitzpatrick; Cecelia Green; Elizabeth E Frauenhoffer; Kevin J French; Yan Zhuang; Lynn W Maines; John J Upson; Emmanuel Paul; Henry Donahue; Timothy J Mosher; Charles D Smith
Journal:  Inflammopharmacology       Date:  2010-10-11       Impact factor: 4.473

8.  Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease.

Authors:  Lynn W Maines; Leo R Fitzpatrick; Cecelia L Green; Yan Zhuang; Charles D Smith
Journal:  Inflammopharmacology       Date:  2010-02-12       Impact factor: 4.473

Review 9.  Sphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammation.

Authors:  Ashley J Snider; K Alexa Orr Gandy; Lina M Obeid
Journal:  Biochimie       Date:  2010-02-13       Impact factor: 4.079

Review 10.  Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling.

Authors:  Deborah A Lebman; Sarah Spiegel
Journal:  J Lipid Res       Date:  2008-04-02       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.